Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 1 | 512 aa | 505 aa | 26.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 1 | 0.5 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.3451 | 0.3451 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.3192 | 0.3192 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 1 | 1 |
Echinococcus granulosus | bloom syndrome protein | 0.002 | 1 | 1 |
Entamoeba histolytica | recQ family DNA helicase | 0.001 | 0.3451 | 0.0381 |
Treponema pallidum | ATP-dependent DNA helicase | 0.001 | 0.3451 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.3451 | 0.3451 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Brugia malayi | Bloom's syndrome protein homolog | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.3451 | 0.3451 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.002 | 1 | 0.5 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Schistosoma mansoni | DNA helicase recq1 | 0.002 | 1 | 1 |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0005 | 0 | 0.5 |
Echinococcus multilocularis | bloom syndrome protein | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.002 | 1 | 0.5 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0005 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Trichomonas vaginalis | DNA helicase recq, putative | 0.002 | 1 | 0.5 |
Schistosoma mansoni | DNA helicase recq5 | 0.002 | 1 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.3451 | 0.0381 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 1 | 0.5 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 1 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Loa Loa (eye worm) | RecQ helicase | 0.002 | 1 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.002 | 1 | 1 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.002 | 1 | 0.5 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.002 | 1 | 0.5 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.002 | 1 | 1 |
Entamoeba histolytica | recQ family helicase, putative | 0.002 | 1 | 1 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.002 | 1 | 1 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.002 | 1 | 0.5 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.001 | 0.3451 | 1 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.